STE

Over the past six months, STERIS Plc (STE) stock has experienced several notable events: In August 2026, STERIS announced its fiscal 2027 first-quarter financial results, reporting EPS that surpassed analyst expectations and revenue that met estimates, alongside plans for a $600 million investment in a new formulated chemistries manufacturing and distribution center in North Carolina. In July 2026, the company raised its quarterly dividend to $0.69 per share, and its stock saw a surge, benefiting from a broader rally in the healthcare sector. In May 2026, STERIS released its Q4 2026 earnings report. In April 2026, Stephens Inc. issued a price target cut, contributing to a general weakness observed across the healthcare sector. In September 2026, STERIS was scheduled to present at the Morgan Stanley Healthcare Conference, with its stock price on September 21, 2026, recorded at $206.97, indicating a 16.8% loss over the preceding 12 months.